Navigation Links
First Genetically Engineered Maize Resistant to Maize Streak Virus Produced in S. Africa

Scientists at the University of Cape Town, South Africa, and colleagues at the South African seed company, PANNAR Pty Ltd, have reportedly developed a resistant variety of maize that could alleviate both food shortages and promote genetically engineered (GE) foods in Africa.

The MSV-resistant maize is the first GE crop developed and tested solely by Africans.

According to Dr. Dionne Shepherd of the University of Cape Town, and her co-authors B. Owor, R. Edema, A. Varsani, D.P. Martin, J.A. Thomson and E.P. Rybicki, maize streak viruses (MSV) are Gemini-viruses that can destroy most of a maize crop.

They are endemic to sub-Saharan Africa and adjacent Indian Ocean islands where they are transmitted by leafhoppers in the genus Cicadulina.

Maize can supply 50 percent of the caloric intake in sub-Saharan Africa but, in certain years, a farmer's entire crop can be wiped out.

In their study presented at the annual meeting of the American Society of Plant Biologists in Chicago on Sunday, Shepher and her colleagues claimed that maize, which originated in Mexico, was carried to Africa in the 1500s and eventually displaced native food crops such as sorghum and millet. aize streak virus, an endemic pathogen of native African grasses, was then carried to maize plants by viruliferous leafhoppers.

They said that African scientists have been working for more than a quarter century on developing resistant varieties of maize by selecting and crossing varieties with various degrees of resistance to the virus.

They said the resistance to the virus requires multiple genes located on different chromosomes, thus ruling out a straightforward process.

The group at the University of Cape Town mutated a viral gene that encodes a protein that the virus needs to replicate itself and inserted it into maize plants. When the virus infects one of these transgenic maize plants, the mutated protein, which is expressed at a high level, prevents the virus from replicating and killing the plant.

The transgenic maize variety has proven consistently resistant to MSV and the trait can be reliably passed on to the next generation and in crosses to other varieties, they opined.

Field trials are scheduled to begin soon, not only to test the effectiveness of the technology in the field, but also to ensure that the GE maize variety has no unintended effects on beneficial organisms that may feed on it.

The resistant maize will also be tested to ensure that the viral protein is digestible and non-allergenic.


'"/>




Related medicine news :

1. First Vaccine Designed for Africa Cleared for Testing in Humans
2. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
3. First human clone is near
4. First Artificial Heart patient has Major setback
5. First head-to-head trials of once weekly Fosamax and Actonel therapies
6. WHO Declares Vietnam First Country to Control SARS
7. Russia Reports First SARS Case
8. Hope for First New Melanoma Treatment in Decades
9. First global SARS meet opens
10. Stanford Medical Center Implements The First Virtual Cardiac Ultrasound
11. Hyderabad To Have Asia’s First Catheter Making Uni
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/24/2017)... ... May 24, 2017 , ... If you are thinking of a visit to San Francisco ... October is the perfect time to visit. , Business Architecture Associates is pleased to offer ... for individuals, as a 4-½ day package for individuals, and as 4-½ day corporate package ...
(Date:5/24/2017)... ... May 24, 2017 , ... Technique, technique, technique – with a ... lifting weights for strength training and exercise or simply lifting heavy objects, advises Dr. ... position is everything,” Dr. Chang says. “Improper technique in lifting anything heavy or an ...
(Date:5/23/2017)... ... 23, 2017 , ... PM360, the premier information resource for ... winners of its 3rd Annual ELITE Awards. The ELITE (Exceptional • Leaders • ... industry today. , Out of more than 500 submissions, 100 winners were selected ...
(Date:5/23/2017)... ... May 23, 2017 , ... London, May 23, 2017: ... serve earlier this month as a Guest Speaker and Contributor to a weeklong series ... and Common Purpose. , Walter Schindler and SAIL Capital ...
(Date:5/23/2017)... IN (PRWEB) , ... May 23, 2017 , ... ... the availability of video chat as a standard feature on its secure clinical ... from text to voice to video depending on the type and urgency of ...
Breaking Medicine News(10 mins):
(Date:5/10/2017)... 10, 2017 CSSi, the global leader in ... research industry, is proud to announce the launch of ... website features both enriched content and a customized layout ... the company,s already well-established position as the top global ... "After many months of hard work, we are delighted ...
(Date:5/9/2017)... , May 9, 2017  Oramed Pharmaceuticals ... ), a clinical-stage pharmaceutical company focused on the ... that the Canadian Intellectual Property Office has granted ... Oral Administration of Exenatide". The patent covers Oramed,s ... GLP-1 is an incretin hormone that ...
(Date:5/8/2017)... FLINT, Mich. , May 8, 2017  Diplomat ... WRB Communications, Inc. ("WRB"), a health care ... . WRB specializes in relationship management ... organizations. WRB will ... of Diplomat,s commercialization support services for manufacturers, biotech firms, ...
Breaking Medicine Technology: